The Pancreatic Cancer Action Network (PanCAN) invites applications for the 2025 Precision Promise Biospecimen and Data Request Proposals. This opportunity provides access to clinical data, tumor samples, and research blood samples collected from participants in the Precision Promise adaptive clinical trial platform to advance translational pancreatic cancer research.
Eligibility criteria:
-
Applicants must be affiliated with the PanCAN Precision Promise adaptive clinical trial platform.
-
Research must have direct applicability to pancreatic cancer.
-
Eligible applicants include academic and industry partners with the necessary expertise and institutional oversight.
Funding details:
-
Catalyst Awards available for innovative projects with potential to impact clinical practice and patient outcomes.
-
Typical award: approximately 300,000 USD for up to 2 years.
-
Funding supports studies validating biomarkers, discovering treatment determinants, or generating novel data.
-
Resources include biospecimens (tumor, serum, plasma) and associated clinical/biomarker data.
Deadline:
-
Application deadline: November 3, 2025, at 9:00 a.m. PT / 12:00 p.m. ET.
-
Decisions announced: late December 2025 to early January 2026.
Where to go for further information:
- Applications must be submitted via ProposalCentral.
- Questions: [email protected].